BioSpace News Archive

Aditxt, Inc. (Nasdaq: ADTX) (“Aditxt” or the “Company”), a biotech innovation company developing and commercializing technologies with a focus on monitoring and modulating the immune system, today announces publication of a mathematical model for predicting the durability and rate of decay of neutralizing antibodies to SARS-CoV-2 in a peer-reviewed research paper in the Journal of Theoretical Biology.

NanoMosaic, a leader in proteomics and multi-omics via its novel MosaicNeedle™ technology and Tessie™ system has expanded its diagnostic capabilities to enable better treatment options for patients.

BioSig Technologies, Inc. today announced that it has been invited to attend the 17th Edition Venice Arrhythmias 2022 Congress—a Heart Rhythm Society sponsored program taking place from October 13-15, 2022 in Venice, Italy.

Collaboration brings together Avectas’ breakthrough cell engineering technology and Inceptor Bio’s CAR-T platform

Araris Biotech AG, a company pioneering a proprietary antibody-drug conjugate (ADC)-linker technology, is pleased to announce the appointment of Filippo Mulinacci, Ph.D., MBA as chief business officer.

SiSaf Ltd, an RNA delivery and therapeutics company, announces that it is initiating the U.S. FDA Regulatory process to obtain an Orphan Drug Designation for SIS-101-ADO, a siRNA therapeutic for patients with Autosomal Dominant Osteopetrosis Type 2 (ADO2), a rare genetic skeletal disorder.

Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced that the U.S. Food and Drug Administration (FDA) granted Emergency Use Authorization (EUA) for a 10-µg booster dose of their Omicron BA.4/BA.5-adapted bivalent COVID-19 vaccine in children 5 through 11 years of age.

COMPASS Pathways plc (Nasdaq: CMPS), a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health, today announced the Phase 3 pivotal program design for COMP360 psilocybin therapy in treatment resistant depression (TRD) during a virtual Capital Markets Day.

PreIPO Corporation™ owner of a suite of proprietary platforms; including: PreIPO-as-a-Service™, Diligence-as-a-Service™, and PreIPO Intelli™, has officially received a full Registered Trademark from the US Patent and Trademark office for “PreIPO®".

Medline and California-based Hoag Memorial Hospital Presbyterian health system have entered into a multi-year prime vendor partnership valued at $200M.